1. Home
  2. ETNB vs BWLP Comparison

ETNB vs BWLP Comparison

Compare ETNB & BWLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • BWLP
  • Stock Information
  • Founded
  • ETNB 2018
  • BWLP 1935
  • Country
  • ETNB United States
  • BWLP Singapore
  • Employees
  • ETNB N/A
  • BWLP N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • BWLP Marine Transportation
  • Sector
  • ETNB Health Care
  • BWLP Consumer Discretionary
  • Exchange
  • ETNB Nasdaq
  • BWLP Nasdaq
  • Market Cap
  • ETNB 1.5B
  • BWLP 1.6B
  • IPO Year
  • ETNB 2019
  • BWLP N/A
  • Fundamental
  • Price
  • ETNB $9.59
  • BWLP $13.71
  • Analyst Decision
  • ETNB Strong Buy
  • BWLP
  • Analyst Count
  • ETNB 8
  • BWLP 0
  • Target Price
  • ETNB $26.43
  • BWLP N/A
  • AVG Volume (30 Days)
  • ETNB 1.5M
  • BWLP 343.5K
  • Earning Date
  • ETNB 08-08-2025
  • BWLP 08-27-2025
  • Dividend Yield
  • ETNB N/A
  • BWLP 12.39%
  • EPS Growth
  • ETNB N/A
  • BWLP N/A
  • EPS
  • ETNB N/A
  • BWLP 1.86
  • Revenue
  • ETNB N/A
  • BWLP $3,387,328,000.00
  • Revenue This Year
  • ETNB N/A
  • BWLP N/A
  • Revenue Next Year
  • ETNB N/A
  • BWLP $2.04
  • P/E Ratio
  • ETNB N/A
  • BWLP $7.97
  • Revenue Growth
  • ETNB N/A
  • BWLP 9.53
  • 52 Week Low
  • ETNB $4.16
  • BWLP $7.86
  • 52 Week High
  • ETNB $11.84
  • BWLP $16.82
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 41.01
  • BWLP 68.08
  • Support Level
  • ETNB $9.82
  • BWLP $13.04
  • Resistance Level
  • ETNB $10.48
  • BWLP $14.08
  • Average True Range (ATR)
  • ETNB 0.49
  • BWLP 0.27
  • MACD
  • ETNB -0.14
  • BWLP 0.05
  • Stochastic Oscillator
  • ETNB 3.70
  • BWLP 77.04

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About BWLP BW LPG Limited Common Shares

BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.

Share on Social Networks: